###begin article-title 0
Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses
###end article-title 0
###begin title 1
Summary
###end title 1
###begin p 2
###xml 209 234 209 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">Carlson and Conboy, 2007a</xref>
###xml 236 256 236 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 287 308 287 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">Brack and Rando, 2007</xref>
###xml 310 335 310 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">Carlson and Conboy, 2007a</xref>
###xml 337 356 337 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">Conboy et al., 2005</xref>
###xml 575 595 572 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 597 616 594 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">Conboy et al., 2003</xref>
###xml 636 644 633 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">systemic</italic>
###xml 720 738 717 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">Brack et al., 2007</xref>
###xml 1423 1430 1399 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 920 926 <span type="species:ncbi:9606">humans</span>
###xml 931 935 <span type="species:ncbi:10090">mice</span>
###xml 1552 1556 <span type="species:ncbi:10090">mice</span>
Muscle stem (satellite) cells are relatively resistant to cell-autonomous aging. Instead, their endogenous signaling profile and regenerative capacity is strongly influenced by the aged, differentiated niche (Carlson and Conboy, 2007a; Carlson et al., 2008) and by the aged circulation (Brack and Rando, 2007; Carlson and Conboy, 2007a; Conboy et al., 2005). With respect to muscle fibers, we previously established that a shift from active Notch to excessive TGF-beta/pSmad3 induces CDK inhibitors in satellite cells, thereby interfering with productive myogenic responses (Carlson et al., 2008; Conboy et al., 2003). In contrast, the systemic inhibitor of muscle repair, elevated in old sera, was suggested to be Wnt (Brack et al., 2007). Here, we examined the age-dependent myogenic activity of sera TGF-beta1, and its potential cross-talk with systemic Wnt. We found that sera TGF-beta1 becomes elevated within aged humans and mice, while systemic Wnt remained undetectable in these species. Wnt also failed to inhibit satellite cell myogenicity, while TGF-beta1 suppressed regenerative potential in a biphasic fashion. Intriguingly, young levels of TGF-beta1 were inhibitory and young sera suppressed myogenesis if TGF-beta1 was activated. Our data suggest that platelet-derived sera TGF-beta1 levels, or endocrine TGF-beta1 levels, do not explain the age-dependent inhibition of muscle regeneration by this cytokine. In vivo, TGF-beta neutralizing antibody, or a soluble decoy, failed to reduce systemic TGF-beta1 and to rescue myogenesis in old mice. However, muscle regeneration was improved by the systemic delivery of a TGF-beta receptor kinase inhibitor, which attenuated TGF-beta signaling in skeletal muscle. Summarily, these findings argue against the endocrine path of a TGF-beta1-dependent block on muscle regeneration, identify physiological modalities of age-imposed changes in TGF-beta1, and introduce new therapeutic strategies for the broad restoration of aged organ repair.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 153 166 153 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R26">Grounds, 1998</xref>
###xml 168 188 168 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R47">Renault et al., 2002</xref>
###xml 366 377 366 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R42">Mauro, 1961</xref>
###xml 595 615 595 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">Collins et al., 2005</xref>
###xml 617 640 617 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R55">Wagers and Conboy, 2005</xref>
###xml 885 910 885 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">Carlson and Conboy, 2007b</xref>
###xml 912 932 912 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 934 953 934 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">Conboy et al., 2003</xref>
###xml 1429 1449 1426 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 1451 1470 1448 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">Conboy et al., 2003</xref>
###xml 1472 1496 1469 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R48">Schultz and Lipton, 1982</xref>
###xml 1792 1817 1789 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">Carlson and Conboy, 2007a</xref>
###xml 1819 1838 1816 1835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">Conboy et al., 2005</xref>
###xml 2033 2052 2030 2049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">Conboy et al., 2005</xref>
###xml 2226 2234 2223 2231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">inhibits</italic>
###xml 2293 2314 2290 2311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">Brack and Rando, 2007</xref>
###xml 2316 2342 2313 2339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R11">Carlson and Faulkner, 1989</xref>
###xml 2344 2369 2341 2366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">Carlson and Conboy, 2007a</xref>
###xml 1648 1652 <span type="species:ncbi:10090">mice</span>
Adult skeletal muscle robustly regenerates throughout an organism's life but, with advancing age, its ability to repair diminishes and ultimately fails (Grounds, 1998; Renault et al., 2002). Muscle satellite cells play a crucial role in this regenerative process, and are physically situated beneath the basal lamina of myofibers (i.e. differentiated muscle cells) (Mauro, 1961). Upon myofiber damage, quiescent satellite cells become activated and begin proliferating as myogenic progenitor cells, which later differentiate into fusion-competent myoblasts and de novo multinucleated myofibers (Collins et al., 2005; Wagers and Conboy, 2005). Although diminished satellite cell numbers have been implicated in the age-related decline of muscle tissue regeneration, several reports identified key molecular changes within Notch and P-Smad3 signaling in the aged endogenous populations (Carlson and Conboy, 2007b; Carlson et al., 2008; Conboy et al., 2003). In this regard, aging of the satellite cell micro-niche was found to promote under-production of Notch ligand Delta, and over-production of TGF-beta. Consequently, satellite cells residing in old muscle fibers express excessive levels of CDK inhibitors, and thus fail to break quiescence and proliferate in response to injury. However, the regenerative responses of aged satellite cells can be rescued, either by forced activation of Notch, or by shRNA targeting of Smad3 (Carlson et al., 2008; Conboy et al., 2003; Schultz and Lipton, 1982). The regenerative capacity of aged muscle can also be enhanced by exposing old satellite cells to young systemic factors - such as when young and old mice are physically connected to share blood circulation (parabiosis), or when aged satellite cells are cultured in the presence of young sera (Carlson and Conboy, 2007a; Conboy et al., 2005). This improved regeneration of aged muscle is due to the enhanced activity of endogenous, aged satellite cells and not from physical contributions of young cells within the common circulation (Conboy et al., 2005). Therefore, in addition to local tissue niches, systemic factors in sera also regulate the regenerative responses of organ stem cells and importantly, the aged circulation inhibits the regenerative potential of even young satellite cells (Brack and Rando, 2007; Carlson and Faulkner, 1989; Carlson and Conboy, 2007a). This evidence suggests that, in the case of heterochronic parabiosis, the inhibitory factors introduced into shared circulation by old partners were continuously removed, or functionally neutralized, by the young partners.
###end p 4
###begin p 5
###xml 111 129 111 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">Brack et al., 2007</xref>
###xml 382 400 382 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">Brack et al., 2008</xref>
###xml 402 424 402 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R30">Ikeya and Takada, 1998</xref>
###xml 426 447 426 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">Le Grand et al., 2009</xref>
###xml 449 467 449 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R38">Marom et al., 1999</xref>
###xml 469 485 469 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R52">Shi et al., 2002</xref>
###xml 487 506 487 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R56">Wagner et al., 2000</xref>
###xml 667 687 664 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 973 988 961 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R37">Li et al., 2004</xref>
###xml 990 1007 978 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R50">Shen et al., 2008</xref>
It was reported that the aged circulation inhibits satellite cell responses by acting through the Wnt pathway (Brack et al., 2007). These findings raised particular interest, since Wnt proteins are not known to be endocrine in nature, and because Wnt signaling was recently demonstrated to enhance myogenic proliferation and differentiation in both embryonic and adult development (Brack et al., 2008; Ikeya and Takada, 1998; Le Grand et al., 2009; Marom et al., 1999; Shi et al., 2002; Wagner et al., 2000). A recent study from our laboratory implicated the Transforming-Growth-Factor Beta (TGF-beta) family in the local inhibition of aged satellite cell responses (Carlson et al., 2008). We therefore decided to explore a potential age-dependent endocrine activity of TGF-beta, and its potential cross-talk with Wnt. Moreoever, we extrapolated our previous findings by narrowing down the anti-myogenic inhibitory activity to one TGF-beta family member, namely TGF-beta1 (Li et al., 2004; Shen et al., 2008).
###end p 5
###begin p 6
###xml 256 279 253 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">Derynck and Zhang, 2003</xref>
###xml 281 295 278 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R40">Massague, 1998</xref>
###xml 297 320 294 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41">Massague and Chen, 2000</xref>
###xml 566 584 557 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">Annes et al., 2003</xref>
###xml 586 609 577 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R28">Hyytiainen et al., 2004</xref>
###xml 1120 1142 1105 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R25">Gellibert et al., 2004</xref>
###xml 1144 1162 1129 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R53">Singh et al., 2003</xref>
###xml 1317 1335 1296 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">Brand et al., 1993</xref>
###xml 1337 1354 1316 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R54">Tang et al., 1999</xref>
###xml 1419 1439 1395 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4">Assoian et al., 1983</xref>
###xml 1441 1455 1417 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R39">Massague, 1987</xref>
###xml 1615 1616 1588 1589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1728 1748 1698 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4">Assoian et al., 1983</xref>
TGF-beta proteins are multifunctional cytokines, secreted by numerous cell types. They are capable of signaling to virtually every cell type, and broadly control cell proliferation, differentiation, apoptosis, inflammation and scarring in various tissues (Derynck and Zhang, 2003; Massague, 1998; Massague and Chen, 2000). TGF-beta ligands are synthesized by cells and secreted as precursor complexes that are composed of mature dimeric C-terminal polypeptides, specifically - the latency associated propeptide (LAP), and the latent TGF-beta binding protein (LTBP) (Annes et al., 2003; Hyytiainen et al., 2004). These complexes can be transported in the blood, and are normally targeted to tissue extracellular matrix (ECM) by the appropriate LTBP, where the mature polypeptide is cleaved. These activated ligands are then capable of binding to their specific receptors, thereby initiating TGF-beta/P-Smad signal transduction. Several validated small molecule inhibitors, which specifically interfere with TGF-beta Receptor I kinase activity, are capable of blocking Smad phosphorylation upon Receptor I ligand binding (Gellibert et al., 2004; Singh et al., 2003). Similarly, an exogenous, dominant-negative form of TGF-beta Receptor II has been shown to effectively prevent TGF-beta signaling in several cell types (Brand et al., 1993; Tang et al., 1999). Both active and inactive TGF-beta proteins are found in sera (Assoian et al., 1983; Massague, 1987), whereby inactive TGF-beta, transported in blood plasma, is available for activation locally in tissues. In this regard, blood cells (mostly platelets and CD4+ T lymphocytes) are known to produce and release high levels of total and biologically-active TGF-beta ligands (Assoian et al., 1983). Considering the strong morphogenic properties of TGF-beta, changes in the levels of either total (latent plus active), or active form alone, are likely to influence immune responses, tissue maintenance and regeneration.
###end p 6
###begin p 7
###xml 237 245 231 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
The results shown here argue against the notion of systemic TGF-beta1 endocrine activity, and strongly suggest that TGF-beta, released by the known process of platelet activation during sera collection, inhibits satellite cell responses in vitro. These findings also suggest that young sera may contain a functional, natural decoy of TGF-beta1, or a competitor of TGF-beta1 signaling pathway (either endocrine or released by platelets). Lastly, our results demonstrate that Wnt antagonizes, rather than synergizes with TGF-beta1-mediated satellite cell response inhibition.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Defining the inhibitory range of systemic TGF-beta1
###end title 9
###begin p 10
###xml 243 265 236 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R22">Dorshkind et al., 2009</xref>
###xml 267 280 260 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R27">Grounds, 2002</xref>
###xml 282 301 275 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R44">Moresi et al., 2008</xref>
The TGF-beta family is composed of roughly 35 different ligands. In addition to other cytokines (e.g. IGF-1, TNF-alpha, IL-6, etc.), many of these have been implicated in the aging process, in general, and with respect to muscle regeneration (Dorshkind et al., 2009; Grounds, 2002; Moresi et al., 2008). Here, we focused on first determining whether the aged circulation is inhibitory to adult myogenesis through the activity of one particular family member - TGF-beta1.
###end p 10
###begin p 11
###xml 520 528 508 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1008 1009 984 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1021 1043 997 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenic proliferation</italic>
###xml 1087 1088 1063 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1099 1123 1075 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myogenic differentiation</italic>
###xml 1126 1145 1102 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">Conboy et al., 2003</xref>
###xml 1147 1166 1123 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">Conboy et al., 2005</xref>
###xml 1168 1189 1144 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R51">Sherwood et al., 2004</xref>
###xml 1224 1232 1200 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1258 1265 1234 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1281 1300 1257 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">Conboy et al., 2005</xref>
###xml 1302 1324 1278 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R18">Conboy and Rando, 2002</xref>
###xml 1343 1355 1319 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD1" ref-type="supplementary-material">Figure S1A-D</xref>
###xml 1394 1419 1370 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">Carlson and Conboy, 2007a</xref>
###xml 1634 1642 1610 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1</xref>
###xml 1647 1659 1623 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD1" ref-type="supplementary-material">Figure S1A-D</xref>
###xml 1682 1683 1658 1659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 1793 1801 1766 1774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1</xref>
###xml 1866 1874 1839 1847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">Figure 3</xref>
###xml 2042 2062 2000 2020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 240 245 <span type="species:ncbi:10090">mouse</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
We specifically postulated that TGF-beta1 levels of young sera are benign, or positive to myogenic regulation, while TGF-beta1 levels found in aged circulation are inhibitory. To explore this, we first depleted TGF-beta1 from young and old mouse serum, followed by re-addition at a range of tested concentrations. Muscle stem cells, derived from young and old mice, were then cultured in the presence of young and old TGF-beta1-depleted, or modified, mouse serum. The regenerative responses of these cells were assayed, in vitro. Sera was depleted of TGF-beta1 by incubation with a TGF-beta1-specific antibody (or isotype-matched control IgG), followed by removal of the TGF-beta1-antibody complexes (or control IgG antibody complexes) using protein G-coated agarose beads. The success of TGF-beta1 depletion was also confirmed by ELISA (not shown). Muscle stem cell myogenic regenerative potential was quantified, based on their ability to generate de-novo myogenic lineages - i.e. BrdU-incorporating desmin+ myoblasts (myogenic proliferation) that differentiate into post-mitotic eMyHC+ myotubes (myogenic differentiation) (Conboy et al., 2003; Conboy et al., 2005; Sherwood et al., 2004). The time course of such de-novo in vitro myogenesis recapitulates in vivo muscle repair (Conboy et al., 2005; Conboy and Rando, 2002), and is shown in Figure S1A-D. In agreement with previous findings (Carlson and Conboy, 2007a), myogenic proliferation (24-48 hours of culture) and myogenic differentiation (48-72 hours of culture) were consistently higher for young satellite cells and in young serum at all time points, as compared to old (Figure 1 and Figure S1A-D). Non-myogenic, desmin- proliferating fibroblasts were less numerous in cultures with experimentally-calibrated levels of TGF-beta1 (Figure 1), and also declined in cultures with exogenous Wnt 3A addition (Figure 3, below). These cells are known to contaminate satellite cell preparations at approximately2-5%, and to expand in the presence of old serum or high levels of TGF-beta (Carlson et al., 2008).
###end p 11
###begin p 12
###xml 133 137 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">only</italic>
###xml 196 207 190 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1A-C</xref>
###xml 365 376 356 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1A-C</xref>
###xml 545 555 530 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">Figure S2A</xref>
###xml 711 721 690 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">Figure S2B</xref>
###xml 825 838 804 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">Figure S2A, B</xref>
###xml 972 992 948 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 1065 1073 1038 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1152 1160 1122 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1</xref>
###xml 1162 1167 1132 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD1" ref-type="supplementary-material">S1A-D</xref>
###xml 1172 1178 1142 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">S2A, B</xref>
###xml 1139 1144 <span type="species:ncbi:10090">mouse</span>
Very interestingly, the productive myogenic proliferation of young and old muscle stem cells was robust in TGF-beta1-depleted serum, only when low levels of recombinant TGF-beta1 were introduced (Figure 1A-C). At 1-5ng/ml (and higher), TGF-beta1 alone sufficed for the inhibition of satellite cell responses, while myogenesis was positively regulated at 0.2 ng/ml (Figure 1A-C). Similarly, myogenic differentiation responses from young cells also peaked in TGF-beta1-depleted serum, which received low levels of exogenous recombinant TGF-beta1 (Figure S2A). In contrast, old cell differentiation was improved by TGF-beta1-depletion from serum alone, as well as in a low range of recombinant TGF-beta1 addition (Figure S2B). The overall differentiation response from old cells was also diminished, as compared to young cells (Figure S2A, B). Since myogenic differentiation was assayed at 48-72 hours of culture, and aged satellite cells have elevated TGF-beta1 production (Carlson et al., 2008), these data suggest that endogenous TGF-beta1 production by old cells, in vitro, counteracts the pro-myogenic effect of TGF-beta1 depletion from mouse serum (Figure 1, S1A-D and S2A, B).
###end p 12
###begin p 13
###xml 440 451 416 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1A-C</xref>
###xml 453 459 429 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">S2A, B</xref>
Together, these data demonstrate that sera-derived TGF-beta1 inhibits satellite cell responses, and that specific levels of TGF-beta1 are required for productive myogenic responses. Even with complete TGF-beta1 depletion, old serum remained less myogenic than young (by approximately10-20%), suggesting that while TGF-beta1 is a main inhibitor of satellite cell responses, it is not the only suppressor of regeneration present in old sera (Figure 1A-C, S2A, B).
###end p 13
###begin title 14
Correlating the inhibitory range of TGF-beta1 with physiological levels found in young and old sera
###end title 14
###begin p 15
###xml 227 240 221 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">Figure 2 A, B</xref>
###xml 349 351 340 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 353 355 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 404 406 395 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 408 410 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 431 440 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">Figure 2A</xref>
###xml 520 529 511 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">Figure 2B</xref>
###xml 601 603 589 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 609 611 597 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 219 225 <span type="species:ncbi:9606">humans</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 367 373 <span type="species:ncbi:9606">humans</span>
###xml 422 428 <span type="species:ncbi:9606">humans</span>
###xml 512 518 <span type="species:ncbi:9606">humans</span>
To further substantiate these conclusions, we correlated the inhibitory range of TGF-beta1 with its levels found in young versus aged sera. Specifically, we analyzed TGF-beta1 levels as a function of age in mice and in humans (Figure 2 A, B). In mice, TGF-beta1 levels sharply increased between 12 months (early post-reproductive age, analogous to 5th-6th decades in humans) and 24 months (analogous to 8th-9th decades in humans), Figure 2A. Moreover, this systemic age-related rise was found to be conserved in humans (Figure 2B), where TGF-beta1 plateaus at its highest systemic levels between the 6th and 9th decades of life (i.e. roughly at the onset and progression of age-imposed regenerative decline). Sera TGF-beta1 for both species thus becomes elevated from the end of the reproductive period, to the end of lifespan.
###end p 15
###begin p 16
###xml 146 154 131 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1</xref>
###xml 180 188 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 631 647 610 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">Abe et al., 1994</xref>
###xml 649 672 628 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R19">Danielpour et al., 1989</xref>
###xml 689 702 668 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD3" ref-type="supplementary-material">Figure S3C, D</xref>
###xml 928 941 904 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD3" ref-type="supplementary-material">Figure S3C, D</xref>
###xml 946 954 922 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1</xref>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 786 791 <span type="species:ncbi:10090">mouse</span>
Curiously, TGF-beta1 levels in young mouse sera (approximately100ng/ml) are predicted to be inhibitory to satellite cell responses (data shown in Figure 1), even if used at 5-10%, in vitro. Therefore, despite apparent pro-myogenic differences between young and old sera, physiological TGF-beta1 levels alone do not explain the inhibitory affects of aged sera on myogenic responses. To determine whether these inhibitory affects correlated with biologically-active TGF-beta1 levels, a bio-activity assay was performed on non-activated serum samples, using the plasminogen activator inhibitor-1 (PAI-1) promoter luciferase-reporter (Abe et al., 1994; Danielpour et al., 1989), and by ELISA (Figure S3C, D). These data clearly demonstrated that while bioactive TGF-beta1 was higher in old mouse serum, as compared to young, the levels in either sera were minute (>4ng/ml) and unlikely to be inhibitory in the 5-10% range examined (Figure S3C, D and Figure 1).
###end p 16
###begin p 17
###xml 442 455 433 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD3" ref-type="supplementary-material">Figure S3E, F</xref>
###xml 883 895 859 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">Figure 2C, D</xref>
Based on published literature, and in agreement with our results, sera and plasma contain little-to-no active TGF-beta1. However, the total TGF-beta1 released by platelets during sera collection becomes activated (e.g. by cells in culture), evoking an interplay between positive and negative regulators that determines the intracellular signaling strength. The platelet source of TGF-beta1 in our serum samples was corroborated, as expected (Figure S3E, F). We further postulated that, in the case of young sera, TGF-beta1 activity is attenuated and may therefore render young sera pro-myogenic. To test this, we compared satellite cell myogenic responses in cultures containing serum with (1) endogenous TGF-beta activity, (2) forced-activated endogenous TGF-beta and (3) forced-activated endogenous TGF-beta, with subsequent TGF-beta1-specific antibody neutralization. As shown in Figure 2C, D, young serum became inhibitory to satellite cell responses (and similar in this regard to old sera) when endogenous young levels of TGF-beta were forced-activated. Importantly, inhibition of myogenic activity was dependent on TGF-beta1 and not related to sera-activation, since TGF-beta1-specific neutralization restored myogenicity to these cultures. Additionally, when mixed with standard young serum, forced-activated young serum was dominant in myogenic inhibition - suggesting that the presence of negative regulators, rather than the removal of positive regulators, accounts for such affects. These data uncover that the strong inhibitory influence of aged sera (as opposed to the pro-myogenic properties of young sera) are not solely explained by age-related differences in TGF-beta1 levels.
###end p 17
###begin title 18
Correlation between systemic levels and myogenic effects of Wnt
###end title 18
###begin p 19
###xml 35 53 35 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">Brack et al., 2007</xref>
###xml 55 74 55 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">Kaykas et al., 2004</xref>
###xml 289 307 265 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">Brack et al., 2007</xref>
###xml 401 413 377 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">Figure 3A, B</xref>
###xml 656 665 632 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">Figure 3B</xref>
###xml 384 390 <span type="species:ncbi:9606">humans</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 623 628 <span type="species:ncbi:10090">mouse</span>
Using a luciferase-reporter assay (Brack et al., 2007; Kaykas et al., 2004), we also measured the systemic levels of biologically-active Wnt, since an age-dependent increase of circulating Wnt (from approximately10ng/ml in young to approximately20ng/ml in old sera) was recently reported (Brack et al., 2007). In our experiments, Wnt was undetectable in young and old serum from both humans and mice (Figure 3A, B). Measurable levels of Wnt in all samples were substantially less than 5ng/ml (based on a recombinant Wnt standard curve). Interestingly, the relative luciferase activity values were actually higher for young mouse serum, as compared to old (Figure 3B).
###end p 19
###begin p 20
###xml 265 283 265 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">Brack et al., 2007</xref>
###xml 797 808 788 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">Figure 3C-F</xref>
###xml 1023 1041 1014 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">Brack et al., 2008</xref>
###xml 1083 1093 1074 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD4" ref-type="supplementary-material">Figure S4A</xref>
###xml 1163 1181 1154 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">Brack et al., 2007</xref>
###xml 1244 1245 1235 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 1250 1251 1241 1242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1621 1632 1606 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F4" ref-type="fig">Figure 4C-F</xref>
###xml 1874 1887 1853 1866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD4" ref-type="supplementary-material">Figure S4B, C</xref>
###xml 1969 1987 1948 1966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">Brack et al., 2007</xref>
###xml 1993 2002 1972 1981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD5" ref-type="supplementary-material">Figure S5</xref>
A rescue of satellite cell responses, in the presence of old serum, was reported to be achieved by the inhibition of Wnt via FRPs. In addition, exogenous Wnt3A was reported to inhibit satellite cell myogenic responses, in favor of fibroblast trans-differentiation (Brack et al., 2007). We thus investigated whether Wnt was potentially synergistic with the TGF-beta1-dependent attenuation of myogenic potential, and if Wnt sera activity might be detected using satellite cell myogenicity assays. To do so, the myogenic potential of young and old satellite cells was examined in the presence of (1) young serum with exogenous Wnt3A (by itself, or simultaneously with exogenous TGF-beta1), or (2) old serum with exogenous FRP3 (by itself, or simultaneously with TGF-beta neutralization). As shown in Figure 3C-F, exogenous FRP inhibition of Wnt did not rescue myogenic responses in old serum. Moreover, exogenous Wnt3A did not reduce myogenic potential in young serum. Consistent with a reported pro-myogenic activity of Wnt (Brack et al., 2008), Wnt3A also enhanced myotube formation (Figure S4A). However, in contrast to the induction of a fibroblastic cell fate (Brack et al., 2007), the presence of non-myogenic fibroblastic cells (e.g. desmin-/BrdU+) was not increased, but reduced in the presence of exogenous Wnt3A, thereby further validating the pro-myogenic activity of Wnt. Wnt modulation also failed to synergize with the TGF-beta1-promoted inhibition of myogenic responses. In contrast, Wnt3A antagonized TGF-beta1 and enhanced the generation of satellite cell-derived, fusion-competent proliferating myoblasts (Figure 4C-F). Additionally, young satellite cells cultured with young serum had less active GSK3beta and more inactive GSK3beta (as compared to old satellite cells cultured with old serum), suggesting that Wnt signaling is stronger in young conditions (Figure S4B, C). These findings were also examined and confirmed using single myofiber assays ((Brack et al., 2007) and Figure S5)). Combined, these results further clarify the respective roles of Wnt and TGF-beta1 in adult myogenesis, demonstrate that Wnt activity is not present in sera (determined by bioactivity and satellite cell myogenicity assays), and also demonstrate that Wnt does not contribute to the TGF-beta1-dependent inhibition of satellite cell myogenic potential.
###end p 20
###begin title 21
Expression of a dominant-negative TGF-beta receptor restores productive myogenic responses to satellite cells exposed to aged serum
###end title 21
###begin p 22
###xml 404 414 392 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD6" ref-type="supplementary-material">Figure S6A</xref>
###xml 505 518 493 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson, 2008</xref>
###xml 762 779 741 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R54">Tang et al., 1999</xref>
###xml 781 802 760 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R61">Yu and Schaffer, 2006</xref>
###xml 974 981 950 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1111 1128 1081 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R54">Tang et al., 1999</xref>
###xml 1143 1155 1113 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F4" ref-type="fig">Figure 4A, B</xref>
###xml 1160 1163 1130 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD6" ref-type="supplementary-material">S6B</xref>
###xml 1523 1532 1484 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F4" ref-type="fig">Figure 4C</xref>
###xml 1614 1624 1572 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD6" ref-type="supplementary-material">Figure S6C</xref>
After justifying our experimental focus on TGF-beta1 as a myogenic inhibitor, we decided to confirm that (1) young sera, as compared to old, down-modulates TGF-beta1 signaling in satellite cells, and that (2) the attenuation of TGF-beta receptor engagement is sufficient to restore myogenic responses in old cultures. TGF-beta receptor levels in satellite cells increase approximately 3-4 fold with age (Figure S6A), suggesting a compounding effect on signaling from an age-dependent elevation of ligand (Carlson, 2008) and receptor. In this regard, we compared the intensity of TGF-beta signaling, and the efficiency of myogenic responses, in satellite cells expressing a TGF-beta dominant-negative receptor II (TGF-beta DN RII), as compared to control vector (Tang et al., 1999; Yu and Schaffer, 2006). Young and old satellite cells were activated by muscle injury, followed by progenitor cell isolation and retroviral transduction with TGF-beta DN RII or control vector, ex vivo. The dominant-negative TGF-beta receptor is an inactive kinase, which effectively inhibits signaling by active TGF-beta ligands (Tang et al., 1999). As shown in Figure 4A, B and S6B, while having no effect on satellite cells cultured with young serum, TGF-beta DN RII expression rescued myogenic proliferation and differentiation in the presence of old serum. The age-related differences in TGF-beta signaling strength, and the attenuation of TGF-beta signaling DN RII expression, were confirmed by nuclear P-Smad3 analysis in muscle cells (Figure 4C). Ectopic expression of truncated TGF-beta DN RII was confirmed by Western blot (Figure S6C).
###end p 22
###begin title 23
###xml 141 148 132 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Systemic delivery of a TGF-beta receptor inhibitor (but not anti-TGF-beta antibody or soluble TGF-beta receptor) restores old muscle repair, in vivo
###end title 23
###begin p 24
###xml 500 507 488 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 625 647 610 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R25">Gellibert et al., 2004</xref>
###xml 649 667 634 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R53">Singh et al., 2003</xref>
###xml 1210 1211 1189 1190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1319 1344 1298 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">Carlson and Conboy, 2007a</xref>
###xml 1346 1366 1325 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 1368 1391 1347 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R55">Wagers and Conboy, 2005</xref>
###xml 1584 1593 1563 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">Figure 5A</xref>
Examination of our data suggested that sera-derived TGF-beta1 was released by platelets during collection procedures. Nevertheless, it remained possible that plasma-based endocrine TGF-beta1 could play a role in the inhibition of satellite cells. In order to examine potential age-dependent endocrine affects of TGF-beta1, and to distinguish them from its local influences, we sought to rejuvenate aged muscle repair by attenuating the TGF-beta pathway through systemic pharmacological intervention, in vivo. Three independent attenuators were used in these experiments: (1) a small molecule inhibitor of TGF-beta RI Kinase (Gellibert et al., 2004; Singh et al., 2003), (2) TGF-beta neutralizing antibody and (3) a decoy composed of the extracellular portion of TGF-beta Receptor II. These molecules were systemically administered for 10 days, followed by CTX muscle injury. Samples were harvested at 5 days post-injury, and examined histologically. The efficiency of adult myogenesis, and age-related changes in this process, were reliably determined by the detection and quantification of newly-formed myofibers. Such de novo fibers are characteristically small, express eMyHC and have centrally-located BrdU+ nuclei - indicating that these cells were recently generated by proliferating, fusion-competent myoblasts (Carlson and Conboy, 2007a; Carlson et al., 2008; Wagers and Conboy, 2005). Newly-formed muscle fibers are typically numerous and visible in young regenerating muscle, but less numerous in old muscle, which instead shows more mononucleated cells and scar formation (Figure 5A).
###end p 24
###begin p 25
###xml 192 204 189 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">Figure 5A, B</xref>
###xml 274 286 268 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD7" ref-type="supplementary-material">Figure S7A-D</xref>
###xml 463 475 451 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">Figure 5A, B</xref>
###xml 647 660 632 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD7" ref-type="supplementary-material">Figure S7E, F</xref>
###xml 700 708 685 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">Figure 3</xref>
###xml 713 715 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD5" ref-type="supplementary-material">S5</xref>
###xml 806 813 791 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 961 974 943 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD7" ref-type="supplementary-material">Figure S7E, F</xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
Muscle regeneration from mice treated by systemic administration of the TGF-beta RI Kinase inhibitor was significantly improved, and similar to the regeneration seen in young control animals (Figure 5A, B), or young animals receiving TGF-beta RI Kinase inhibitor treatment (Figure S7A-D). In contrast, systemic administration of either TGF-beta neutralizing antibody, or soluble TGF-beta Receptor II, failed to improve myogenic regenerative capacity in old mice (Figure 5A, B). To control for the biological activity of the anti-TGF-beta neutralizing antibody, we performed intra-muscular injections (which enhanced old muscle repair as expected (Figure S7E, F)). In agreement with the data shown in Figure 3 and S5, experimental attenuation of Wnt (by FRP) did not improve the regeneration of old muscle, in vivo. Further, Wnt attenuation did not synergize with intra-muscular attenuation of TGF-beta, which alone sufficed for the rescue of old muscle repair (Figure S7E, F).
###end p 25
###begin p 26
###xml 431 440 419 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">Figure 5B</xref>
###xml 569 576 554 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 698 707 680 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">Figure 6A</xref>
###xml 867 876 840 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">Figure 6A</xref>
###xml 1073 1091 1043 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">Annes et al., 2003</xref>
###xml 1093 1115 1063 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24">Feng and Derynck, 2005</xref>
###xml 1117 1140 1087 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R28">Hyytiainen et al., 2004</xref>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
To control for potential half-life differences of the anti-TGF-beta neutralizing antibody, as compared to TGF-beta RI Kinase inhibitor, we also employed osmotic subcutaneous pumps for the constitutive systemic delivery of these molecules. Under these conditions, the anti-TGF-beta neutralizing antibody still failed to significantly enhance repair of old muscle, while TGF-beta RI Kinase inhibitor robustly promoted muscle repair (Figure 5B). These key data suggest that endocrine TGF-beta1 does not play a major role in the age-related decline of muscle regeneration, in vivo. Furthermore, ELISA assays on systemic TGF-beta1 levels not only corroborated, but in fact strengthened this conclusion (Figure 6A). These data demonstrated that TGF-beta1 neutralizing antibody, or soluble TGF-beta Receptor II, failed to reduce circulating levels of TGF-beta1 in old mice (Figure 6A). In agreement with other reports, our findings suggest that bio-active TGF-beta1 is not present in the circulation, which would be recognizable by the herein tested antibody or cognate receptor (Annes et al., 2003; Feng and Derynck, 2005; Hyytiainen et al., 2004).
###end p 26
###begin p 27
###xml 205 217 199 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">Figure 6B, C</xref>
###xml 360 380 351 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 792 804 768 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">Figure 6B, C</xref>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
The rejuvenating effects produced by TGF-beta RI Kinase inhibitor systemic delivery are best explained by the attenuation of local TGF-beta signaling in all tissues, including skeletal muscle. As shown in Figure 6B, C, this hypothesis is directly substantiated by our experimental data. Namely, the high levels of P-Smad3 and TGF-beta1, typical of old muscle (Carlson et al., 2008), are significantly reduced in old mice receiving systemically-administered TGF-beta RI Kinase inhibitor, but not in old mice receiving anti-TGF-beta antibody or soluble receptor. Importantly, osmotic pump delivery TGF-beta RI Kinase inhibitor not only reduced P-Smad3 levels, but also diminished levels of TGF-beta1 production by muscle cells, suggesting positive feed-back regulation in the TGF-beta pathway (Figure 6B, C).
###end p 27
###begin p 28
###xml 192 199 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 264 284 258 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 716 724 701 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 726 735 711 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figures 1</xref>
###xml 737 738 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">2</xref>
###xml 740 742 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">S2</xref>
###xml 814 821 796 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Together, these data establish that systemically-administered TGF-beta RI Kinase inhibitor acts locally to attenuate TGF-beta1/pSmad3 signaling in satellite cells, and restores muscle repair, in vivo. These findings are also in agreement with our previous report (Carlson et al., 2008). In contrast, systemic levels and intra-muscular TGF-beta1 signaling strength are not down-modulated, and old muscle repair is not enhanced by circulating neutralizing antibody or soluble receptor (which do not access endocrine or tissue TGF-beta when administered systemically). Thus, while TGF-beta1 is released by platelets during sera collection, and does exhibit an inhibitory and age-dependent influence on satellite cells, in vitro (Figures 1, 2, S2), there is no evidence for TGF-beta1 endocrine anti-myogenic activity, in vivo.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 231 240 225 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figures 1</xref>
###xml 242 243 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">2</xref>
###xml 209 214 <span type="species:ncbi:10090">mouse</span>
###xml 219 224 <span type="species:ncbi:9606">human</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 410 416 <span type="species:ncbi:9606">humans</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
###xml 1224 1228 <span type="species:ncbi:10090">mice</span>
###xml 1233 1239 <span type="species:ncbi:9606">humans</span>
The data presented in this work establish the anti-regenerative properties and inhibitory range of TGF-beta1. These data also demonstrate that the age-related increase in TGF-beta1 levels is conserved between mouse and human sera (Figures 1, 2), and may therefore be universal to the aging process of mammals. In our studies, there was less variation in measurable TGF-beta1 levels within mice (as compared to humans), likely owing to their environmental and genetic homogeneity. It is also important to note that our reported human TGF-beta1 levels are representative of the healthy aging population, as individuals for these studies were pre-screened for confounding medical conditions. Despite this, none of the aged individuals (>/= 60yrs) had less-than-measurable levels of TGF-beta1, as opposed to many of the young individuals (</= 30yrs) enrolled in these studies. Considering that TGF-beta1 is broadly-produced, and signals to a variety of cells, the age-related and evolutionarily-conserved elevation of its functional levels in old sera may affect stem cell responses in various other tissues. Such a finding may provide a preliminary explanation for the general organ stem cell regenerative potential decline of mice and humans.
###end p 30
###begin p 31
###xml 86 94 83 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1</xref>
###xml 176 185 170 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F4" ref-type="fig">Figures 4</xref>
###xml 187 188 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">6</xref>
###xml 304 312 295 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1</xref>
###xml 431 440 422 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figures 1</xref>
###xml 442 443 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F4" ref-type="fig">4</xref>
###xml 444 445 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">6</xref>
###xml 668 696 656 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R23">Dunker and Krieglstein, 2000</xref>
###xml 851 868 836 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R31">Itoh et al., 2003</xref>
###xml 870 896 855 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R32">Kamanga-Sollo et al., 2003</xref>
###xml 898 920 883 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R43">McPherron et al., 1997</xref>
###xml 922 941 907 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R45">Muller et al., 2003</xref>
###xml 943 963 928 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R57">Wharton et al., 2004</xref>
###xml 1162 1171 1141 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figures 1</xref>
###xml 1173 1174 1152 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">2</xref>
###xml 1179 1181 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD1" ref-type="supplementary-material">S1</xref>
###xml 1183 1184 1162 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">2</xref>
###xml 1649 1669 1613 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">Andrews et al., 2006</xref>
###xml 1671 1691 1635 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">Bonyadi et al., 1997</xref>
###xml 1693 1713 1657 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">Brionne et al., 2003</xref>
###xml 1715 1735 1679 1699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R35">Larsson et al., 2001</xref>
###xml 1737 1756 1701 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R46">Oshima et al., 1996</xref>
###xml 2018 2036 1982 2000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R20">Datto et al., 1999</xref>
###xml 2038 2055 2002 2019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R60">Yang et al., 1999</xref>
###xml 2199 2219 2160 2180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">Brionne et al., 2003</xref>
###xml 2221 2244 2182 2205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R58">Wyss-Coray et al., 1997</xref>
###xml 2246 2269 2207 2230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R59">Wyss-Coray et al., 2001</xref>
###xml 1463 1467 <span type="species:ncbi:10090">mice</span>
###xml 2081 2085 <span type="species:ncbi:10090">mice</span>
With respect to satellite cell activation, TGF-beta1 operates in a threshold fashion (Figure 1), and appears to function through the TGF-beta II Receptor and P-Smad signaling (Figures 4, 6). Our findings suggest that certain levels of TGF-beta1 are actually required for normal satellite cell responses (Figure 1). Experimental down-modulation of this pathway is therefore expected to be typically harmful, unless it is transient (Figures 1, 4-6) or performed to precise "beneficial" levels. These conclusions fit well with studies, reporting that among other important functions, TGF-beta1 signaling is needed for efficient immune cell and wound clearance responses (Dunker and Krieglstein, 2000). TGF-beta proteins have been shown to behave as morphogens which, depending on concentration, induce various gene subsets and promote different effects (Itoh et al., 2003; Kamanga-Sollo et al., 2003; McPherron et al., 1997; Muller et al., 2003; Wharton et al., 2004). The morphogenic nature of the TGF-beta family agrees with our conclusion that, at specific concentrations, TGF-beta1 is permissive or non-permissive to productive myogenic regenerative responses (Figures 1, 2 and S1, 2). Consequently, pronounced down-modulation of TGF-beta1 causes immune disorders, inflammation, and organ dysfunction. This complicates the use of TGF-beta1 attenuators, such as antibodies and small molecules (delivered by pumps, or otherwise), or the use of genetically-altered mice, which do not survive into old age if they harbor TGF-beta pathway insufficiencies. For example, genetic deficiencies in TGF-beta1,2,3, TGF-beta RI,II,III, Smad2, Smad4 and others (Andrews et al., 2006; Bonyadi et al., 1997; Brionne et al., 2003; Larsson et al., 2001; Oshima et al., 1996) all cause embryonic or neonatal lethality, due to the abnormal development of various organ systems. Furthermore, Smad3 knockout animals survive after birth, but die before old age due to chronic infections, accelerated rate of cancers and T-cell dysfunction (Datto et al., 1999; Yang et al., 1999). TGF-beta1 heterozygous mice also survive after birth, but have increased neuronal abnormalities, inflammation and fibrosis of blood vessels (Brionne et al., 2003; Wyss-Coray et al., 1997; Wyss-Coray et al., 2001). Combined, these data agree with our conclusion that prolonged, or sustained, experimental down-modulation of TGF-beta1 levels will perturb cellular function.
###end p 31
###begin p 32
###xml 296 304 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 306 315 297 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figures 1</xref>
###xml 320 321 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">2</xref>
###xml 421 428 409 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 430 439 418 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">Figures 5</xref>
###xml 444 445 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">6</xref>
###xml 635 644 620 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figures 1</xref>
###xml 649 650 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">2</xref>
###xml 825 844 807 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">Conboy et al., 2005</xref>
Our work reveals that platelet-derived sera TGF-beta1 levels, or endocrine TGF-beta1 levels, do not explain the age-dependent inhibition of tissue regeneration by this cytokine. Specifically, if all endogenous young sera TGF-beta1 were active, it would readily suppress satellite cell responses, in vitro (Figures 1 and 2). Further, neutralization of circulatory TGF-beta1 is not achievable by experimental ligand traps, in vivo (Figures 5 and 6). These data suggest the presence of a natural TGF-beta1 modifier/decoy (predictably more active in the young), which is likely endocrine in nature, or released during platelet activation (Figures 1 and 2). Future work on the characterization of such natural systemic antagonist(s) of TGF-beta1 may also explain the regenerative phenotypes observed in hetereochronic parabiosis (Conboy et al., 2005).
###end p 32
###begin p 33
###xml 140 160 137 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 395 404 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">Figures 5</xref>
###xml 409 410 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">6</xref>
###xml 645 652 636 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 654 663 645 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">Figures 5</xref>
###xml 668 669 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">6</xref>
###xml 836 844 821 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">Figure 6</xref>
###xml 946 966 928 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
This work further confirms and extrapolates the autocrine/paracrine mode of TGF-beta age-dependent inhibition of organ stem cell responses (Carlson et al., 2008). Specifically, old tissue repair was improved only when P-Smad3 levels were attenuated locally in muscle (e.g. through small molecule systemic delivery), which is also expected to attenuate TGF-beta signaling broadly in all tissues (Figures 5 and 6). In contrast, systemically-administered neutralizing antibody, or soluble receptor, failed to restore old muscle repair. These molecules did not attenuate endocrine or local TGF-beta1, nor diminish P-Smad3 levels in satellite cells, in vivo (Figures 5 and 6). These data also predict the presence of a positive feed-back loop, where a certain TGF-beta signaling strength is required to maintain TGF-beta1 ligand expression (Figure 6), which was additionally suggested by TGF-beta level reduction in muscle treated with RNAi to Smad3 (Carlson et al., 2008). It remains to be determined whether there is a broad TGF-beta1 increase within old tissues (in addition to skeletal muscle fibers), or if a narrow subset of cells in aged organisms over-produce TGF-beta1.
###end p 33
###begin p 34
###xml 338 358 332 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 658 667 649 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">Figures 2</xref>
###xml 669 670 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">3</xref>
###xml 672 674 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">S2</xref>
###xml 676 678 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD4" ref-type="supplementary-material">S4</xref>
###xml 744 762 735 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">Brack et al., 2008</xref>
###xml 1152 1170 1143 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">Brack et al., 2008</xref>
###xml 1172 1193 1163 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">Le Grand et al., 2009</xref>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
While the involvement of additional TGF-beta family members (or other age-dependent cytokines involved with muscle repair decline) is certainly not ruled out, TGF-beta1 was identified here as a key, age-related inhibitor of myogenic responses. Additionally, myostatin was previously reported to not locally increase in old muscle tissue (Carlson et al., 2008), thus implicating the ubiquitous TGF-beta1, rather than tissue-specific family members in these age-related phenotypes. While other circulatory molecules may contribute to the aging of muscle stem cell responses, our data suggest that Wnt is not a systemic age-dependent attenuator of myogenicity (Figures 2, 3, S2, S4). These data are in apparent disagreement with those reported by Brack et al., 2008, and further study will resolve whether Wnt is present in the circulation, is upregulated with aging and becomes inhibitory to myogenic responses at some age-specific level. Of note, in reports examining Wnt in young mice only, it is suggested that Wnt promotes satellite cell myogenicity for both differentiation of myoblasts to myotubes, and with respect to satellite cell self-renewal (Brack et al., 2008; Le Grand et al., 2009).
###end p 34
###begin p 35
###xml 343 363 340 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
Comprehensively, these studies identify physiological sources of TGF-beta1 that are responsible for age-related muscle repair inhibition, and point toward novel therapeutic strategies for the enhancement of organ regenerative potential. In proof-of-principle research, intra-muscular attenuation of Smad3, by RNAi, rescued aged muscle repair (Carlson et al., 2008). Such methodology, however, is not easily applicable to an organism-wide restoration of old organ repair. In contrast, our herein reported systemic delivery of a TGF-beta receptor kinase inhibitor allows one to reach all tissues, to recalibrate TGF-beta1 ligand levels to their youthful states and to potentially rejuvenate their regenerative function.
###end p 35
###begin title 36
Experimental Procedures
###end title 36
###begin title 37
Cell Culture
###end title 37
###begin p 38
###xml 122 141 122 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">Conboy et al., 2003</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 349 354 <span type="species:ncbi:10090">mouse</span>
###xml 419 424 <span type="species:ncbi:9796">horse</span>
Myofiber explant cultures and primary myogenic progenitor cells were generated from C57/Bl6 mice as described previously (Conboy et al., 2003). Myoblasts were maintained in growth media (Ham's F-10, 20% FBS, 5 ng/ml basic-FGF, and penicillin-streptomycin). Opti-MEM was used to culture myofiber explants in 10% young, 10% old, or 10% young plus old mouse serum (5% each). Differentiation media consisted of DMEM and 5% horse sera. Basic-FGF was obtained from Sigma (St. Louis, MO) and R&D systems (Minneapolis, MN), Opti-MEM was obtained from Invitrogen (Carlsbad, CA), and all other cell culture reagents were obtained from Cellgro (Herndon, VA).
###end p 38
###begin title 39
Retrovirus production and transfection
###end title 39
###begin p 40
###xml 72 90 69 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">Kundu et al., 2000</xref>
###xml 92 109 89 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R49">Shah et al., 2002</xref>
###xml 254 281 248 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R29">Ignowski and Schaffer, 2004</xref>
###xml 1174 1195 1153 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R61">Yu and Schaffer, 2006</xref>
###xml 720 726 <span type="species:ncbi:9913">bovine</span>
###xml 1000 1026 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
pMSCV- TbetaRIIDN retroviral vector was a kind gift from Dr. Chung Lee (Kundu et al., 2000; Shah et al., 2002). TbetaRIIDN was excised from the vector using EcoR I/BamH I, blunted with Klenow (NEB) and inserted into the MoMLV retroviral vector pCLPCGFP (Ignowski and Schaffer, 2004). pCLPCGFP was first digested with BamHI, following which it was also blunted with Klenow and ligated with the TbetaRIIDN fragment. The resulting pCLPC TbetaRIIDN vector was sequenced to confirm its sequence and directionality of insertion. A plasmid made by ligating the blunt ends of the pCLPC vector was used as a control. To produce retrovirus, HEK 293T cells (cultured in Iscove's modified Dulbecco's medium (Hyclone) with 10% fetal bovine serum (Invitrogen) and 1% penicillin-streptomycin (Gibco) and maintained at 37degreesC and 5% CO2) were co-transfected with the retroviral vector (pCLPC TbetaRIIDN or control plasmid) and the helper plasmids pCMV-VSVG, a vector encoding the viral envelope protein from the vesicular stomatitis virus and pCMV-gagpol, a vector encoding the enzymatic and structural retroviral proteins, using the calcium phosphate transfection method as described (Yu and Schaffer, 2006). Medium was changed 12 hrs after transfection. 48 hours after transfection, the cell culture supernatant, containing the virus, was collected and purified by ultra centrifugation through 20% sucrose in PBS and resuspended in PBS. The virus also encoded a gene that rendered it resistant against puromycin, and was titered on 293T cells using WST1 reagent (Roche) following the manufacturer's protocol.
###end p 40
###begin p 41
###xml 202 203 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 238 239 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
Viral transduction was performed on bulk myofiber explants with activated satellite cells, isolated 3 days post-injury from CTX-injured young and old animals. Cells were infected with TbetaRIIDN (2 x 106 TU/ml), or control viruses (1 x 107 TU/ml), at assay-dependent MOIs, and cultured for 48hrs in the presence of OPTI-MEM, + 5% young or old mouse serum prior to fixation and analysis. No tetracycline was added in these experiments.
###end p 41
###begin title 42
Animal Strains
###end title 42
###begin p 43
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Young (2-4 month) and old (20-24 month) C57/Bl6 male mice were obtained from Jackson Laboratories (Bar Harbor, ME) and NIA (Bethesda, MD), respectively.
###end p 43
###begin title 44
Antibodies and Reagents
###end title 44
###begin p 45
Antibody against embryonic myosin heavy chain (developmental) was purchased from Vector Laboratories (Burlingame, CA) and the Developmental Studies Hybridoma Bank. Phosphorylated-Smad2/3 antibody (1:200 WB (Western blot), 1:100 IF (immunofluorescence) was obtained from Chemicon (Temecula, CA) and Santa Cruz Biotechnologies (sc-11769). Bioactivity-neutralizing antibody against TGF-beta1 (MAB240), rTGF-beta1 (240-B) rWnt3a (1324-WN) sFRP3 (592-FR) and huTGF-beta RIII (242-R3) were purchased from R&D Systems (Minneapolis, MN). Delta (9120) and TGF-beta Receptor I (SC 9048) (1:100 WB) antibodies were obtained from Santa Cruz Biotechnologies (Santa Cruz, CA). Activated Notch (1:500 WB) (ab8925) and BrdU (1:100 IF) (ab6326) antibody were obtained from Abcam (Cambridge, MA). Desmin (1:25 IF) (clone DE-U-10, #D1033) and actin (1:250 WB, A5060) antibodies were purchased from Sigma.
###end p 45
###begin title 46
Muscle Injury
###end title 46
###begin p 47
###xml 420 427 420 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Isoflurane was used to anesthetize the animal during the muscle injury procedure. For bulk myofiber satellite cell activation, tibialis anterior and gastrocnemius muscles were injected with cardiotoxin I (CTX, Sigma) dissolved at 100 micrograms per milliliter in PBS, at 2-5 sites for each muscle for approximately 50 microliters/gram muscle. Muscles were harvested 3 days later. For focal injury, to assay regeneration in vivo, 2-3 microliters of 1 milligram per milliliter cardiotoxin was injected at one site to the middle of the tibialis anterior, or two sites at the gastrocnemius, and muscle harvested 5 days later. In some experiments, FRP3 (500ng), anti-TGF-beta (10ng), FRP3/anti-TGF-beta or IgG (10ng) were injected intramuscularly into injury sites, 24 hours following initial injury. In these studies, BrdU (50mg/kg) was injected IP at 2 days following injury.
###end p 47
###begin title 48
Immunofluorescence and histological analysis
###end title 48
###begin p 49
###xml 140 159 140 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">Conboy et al., 2003</xref>
###xml 822 829 821 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1058 1077 1045 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">Conboy et al., 2003</xref>
###xml 1626 1651 1613 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R12">Carlson and Conboy, 2007a</xref>
###xml 1653 1673 1640 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
All muscle tissue was dissected, flash frozen in OCT compound (Tissue Tek) and cryo-sectioned at 8-10 micrometers, as previously described (Conboy et al., 2003). Muscle sections were stained with aqueous hematoxylin and eosin (H&E), as per the manufacturer's instructions (Sigma-Aldrich, St. Louis, MO). Regeneration and myogenic potential was quantified by examining injury sites from representative sections along the muscle (spanning the volume of injury), then measuring the injured/regenerating area using Adobe Photoshop Elements. In all experiments, regenerating tissue was obtained from both tibialis anterior and gastrocnemius muscles. Cryo-sectioning was performed through the entire volume of muscle (typically 50-70 sections total, done at 200mum intervals), thereby serially reconstituting the entire tissue, ex vivo. Myofiber regeneration was quantified by counting total newly-regenerated fibers at injury epicenters, per volume of injury (typically approximately1mm2) and dividing fibers per area. Immunostaining was performed as described (Conboy et al., 2003). Briefly, after permeablization in PBS+1% FBS+0.25% Triton-X-100, tissues and cells were incubated with primary antibodies in staining buffer (PBS+1% FBS) for 1 hour at room temperature, followed by 1 hour incubation fluorochrome-labeled secondary antibodies (ALEXA, Molecular Probes; Carlsbad, CA, at 1:1000). P-Smad2/3 and BrdU-specific immunostaining required an extra step of 2M HCl treatment (denaturation of DNA) before permeablization. The index of myogenic potential was evaluated, based on BrdU/eMyHC costaining, as previously described (Carlson and Conboy, 2007a; Carlson et al., 2008).
###end p 49
###begin title 50
Depletion of TGF-beta from Culture Media
###end title 50
###begin p 51
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Opti-MEM containing either 10% young or old mouse serum was incubated in the presence of 5 microgram per milliliter TGF-beta antibody (R&D Systems) overnight at 4degreesC. Protein-G agarose was then added to the media/antibody mix and incubated for 4 hours at 4degreesC. The mixture was then centrifuged at 10,000 RCF for 5 minutes. Supernatant was collected and centrifugation was repeated. TGF-beta depleted supernatant was used for culture.
###end p 51
###begin title 52
Plasma/Platelet Preparation and Activation of Serum TGF-beta
###end title 52
###begin p 53
For plasma preparation, less than 100mul was collected from the tail into 10mul of 100mM EDTA. Red blood cells were removed by sedimentation, twice at 150g for 10 min, followed by platelet sedimentation for 10 min at 1500g. Platelet-poor plasma was re-cleared by an additional sedimentation for 10 min at 1500g. Platelets were washed once with 0.08M sodium citrate, pH 6/0.9g/liter sodium chloride, sedimented again at 1500g, and resuspended in cold water before flash freezing. Serum TGF-beta was activated by mixing 100mul of serum with 100mul 10M Urea/2.5M acetic acid, followed by incubation for 10 min at room temperature. Acid treatment was neutralized with 2.7M sodium hydroxide/1M HEPES, and salts were removed via ultrafiltration (Vivaspin 500, 3kDa MWCO, GE Healthcare).
###end p 53
###begin title 54
Measurement of Bioactive Levels of TGF-beta in Serum
###end title 54
###begin p 55
###xml 44 63 44 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">Conboy et al., 2003</xref>
###xml 419 435 410 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">Abe et al., 1994</xref>
###xml 451 452 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 337 341 <span type="species:ncbi:452646|species:ncbi:9666">mink</span>
###xml 577 583 <span type="species:ncbi:9913">bovine</span>
###xml 694 699 <span type="species:ncbi:10090">mouse</span>
Serum was isolated as previously described (Conboy et al., 2003). Briefly, blood cells were coagulated at 37degreesC for 15 min and centrifuged to isolate serum. In the Luciferase-reporter trans-activation assay, the biological activity of TGF-beta was measured via induction of the plasminogen activator inhibitor-1 (PAI-1) promoter in mink lung epithelial cells stably expressing a PAI promoter-luciferase construct (Abe et al., 1994). Briefly, 3x104 transfected cells were plated in 96-well plates in 50 microliters of Dubelco's Modified Eagle Medium (DMEM) with 0.5% fetal bovine serum and incubated for 3 hours at 37degreesC in 5% CO2. Experimental sample (50muL of DMEM with young or old mouse serum at 1:2 and 1:10 dilutions) was added to triplicate wells and incubated for 16 hours. Cells were then washed with PBS and lysed. The luciferase activity in the lysate was measured in an EG&G Berthold Microlumat LB 96P (Oak Ridge, TN) for 10 seconds, immediately following auto-injection of 20 microliters of luciferase substrate and recorded as relative light units integrated over time. A TGF-beta standard curve was performed to determine the total amount of active TGF-beta. Neutralizing antibodies specific for individual TGF-beta (R&D Systems) were added to demonstrate specificity.
###end p 55
###begin title 56
Measurement of Bioactive Levels of WNT in Serum
###end title 56
###begin p 57
###xml 41 60 41 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">Kaykas et al., 2004</xref>
L cells, stably harboring SuperTopFlash (Kaykas et al., 2004) and pEF1-LacZ constructs ("LSL cells"), were plated into 96-well microtiter dishes at approximately 80-90% confluency. After approximately6 hours post-plating, media was removed and LSL cells were treated with serum or Wnt protein diluted into complete media (DMEM/10% FBS plus antibiotics) for approximately 16 hours at 37degreesC Luciferase activity was measured in a Lumat LB 9507 luminometer (Berthold) using the Dual light TROPIX kit according to manufacturer's instructions. All assays were performed in triplicate, and the relative luciferase units were normalized to LacZ readings.
###end p 57
###begin title 58
Measurement of serum TGF-beta levels
###end title 58
###begin p 59
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 76 81 <span type="species:ncbi:10090">Mouse</span>
###xml 444 449 <span type="species:ncbi:9606">human</span>
###xml 815 820 <span type="species:ncbi:9606">Human</span>
Mouse blood was collected upon euthanasia, and serum was prepared as above. Mouse serum levels were determined by sandwich ELISA, as per the manufacturer's protocol (R&D Systems #DY1679), with the recommended pre-treatment of sample with acid/urea, followed by neutralization. To avoid dilution effects on measurement, peak readings calculated from the corrected dilution curve were used for comparison among samples. Serum from aged and young human subjects was collected and stored in aliquots at -70degreesC until used. Young donors were between 20-35 years of age and elderly donors were between 65-90 years of age. Elderly subjects belonged to middle-class socio-economic status, and were living independently. This study was approved by the Institutional Review Board of the University of California, Irvine. Human TGF-beta levels were determined using a specific ELISA kit (BD Biosciences, San Jose, CA) with the recommended pre-treatment of sample with acid, followed by neutralization with the base.
###end p 59
###begin title 60
Western Blot Analysis
###end title 60
###begin p 61
Western blotting was performed according to standard protocols. Typically, thirty micrograms of protein extract from myofibers, or satellite cells, were run on SDS PAGE gels (Bio-Rad, Hercules, CA). Primary antibodies were diluted in 5% nonfat milk in 1x PBS-T at indicated dilutions (see above). HRP-conjugated secondary antibodies (Santa Cruz Biotech) were diluted 1:1000 in 1x PBS, 2%BSA, and 0.5% Tween-20. Nitrocellulose membranes were treated with secondary antibodies for 1 hour at room temperature, developed using ECL reagent (Amersham), and imaged on a Bio-Rad Chemidoc XRS.
###end p 61
###begin title 62
Pharmacological Intervention
###end title 62
###begin p 63
For modulating TGF-beta levels systemically, the TGF-beta RI Kinase inhibitor (Calbiochem/EMD Chemicals Gibbstown, NJ catalog # 616452) was delivered at 10 nanomoles over 2 weeks, by injecting twice daily for 4 weeks (subcutaneous) with 100 microliters of a 1:10 dilution of 3.4 millimolar inhibitor (dissolved in dimethylsulfoxide), diluted in PBS with diluted DMSO as control. Five days before the end of treatment, muscle was injured as described. At the end of treatment, animals were sacrificed and muscles were collected. BrdU was injected (intraperitoneal) at 3 days post-injury to label proliferating, fusion-competent myoblasts.
###end p 63
###begin title 64
Statistical Analysis
###end title 64
###begin p 65
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
A minimum of 3 replicates were performed for each experimental condition. Quantified data are presented as means and standard deviations. Analysis of variance (ANOVA) was used to compare data from different experimental groups. P values of < 0.05 were considered statistically significant.
###end p 65
###begin title 66
Supplementary Material
###end title 66
###begin title 67
Figure S1: Time-course analysis of myogenic proliferation and differentiation
###end title 67
###begin p 68
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 251 253 251 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 481 486 481 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C, D.</bold>
A. Summarized data from myofiber explant cultures, grown for 24 and 48hrs in isochronic (Y-Y, O-O) and heterchronic (Y-O, O-Y) conditions. Data depicts representative profile of desmin+/BrdU+ cells (% myogenic proliferation), shown as mean % +/- S.D. B. Summarized data from myofiber explants, cultured for 48 and 72hrs under differentiation-inducing conditions. Data depicts representative profile of eMyHC-associated nuclei (% myogenic differentiation), shown as mean % +/- S.D. C, D. Profiles of data (shown in A and B) demonstrate expected reduction in myogenic proliferation from 24h to 48hrs, versus increases degree of differentiation from 48 to 72hrs.
###end p 68
###begin title 69
Figure S2: Old serum inhibits myogenic differentiation by TGF-beta-dependent mechanism
###end title 69
###begin p 70
###xml 13 21 13 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1</xref>
###xml 373 374 367 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 379 380 373 374 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
As shown for Figure 1, young and old myofiber-associated myogenic progenitor cells were isolated 3 days post injury and cultured overnight in Opti-MEM containing either 10% young serum (YS), 10% old (OS), TGF-beta1 antibody depleted serum alone, or with fixed amounts of recombinant TGF-beta1 in the culture system. Cells were cultured with their specific serum for 24hrs (A and B), and transferred to differentiation medium for additional 48hrs. BrdU was added for the last 2 hours to measure proliferation. Cells were fixed and immunostained for eMyHC and total eMyHC-associated nuclei/total de novo myotubes, +/-S.D. *p < 0.05 for isochronic BrdU, with Hoechst labeling of all nuclei. Results displayed as the mean percent of Y+YS/O+OS 0ng/ml, compared to 0.5ng/ml, and 5.0ng/ml compared to 0.5ng/ml; n=3.
###end p 70
###begin title 71
Figure S3: Old animals have high levels of total platelet and bioactive sera TGF-beta
###end title 71
###begin p 72
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 114 115 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 403 405 389 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 515 516 498 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 3 8 <span type="species:ncbi:10090">Mouse</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
A. Mouse bioactive TGF-beta levels were measured using a PAI-luciferase reporter transactivation assay and ELISA (B) performed without acid-based activation of latent TGF-beta. Recombinant TGF-beta1 protein was used to create the standard curve. Old serum has higher levels of active TGF-beta1 when compared to young. Means +/- s.d. are shown; p </= 0.01 when compared to young, n=3 for A, n=4-5 for B. C. Isolated platelets and plasma, from young and old mice, were analyzed for levels of TGF-beta, quantified in (D) as relative intensity for TGF-beta-specific Western blot, +/-S.D. Actin was used a loading control. n=6 (3 young compared to 3 old). *p < 0.05 for old platelets compared to young.
###end p 72
###begin title 73
Fig S4: Old serum inhibits myogenic differentiation by a TGF-beta-dependent and Wnt-independent mechanism
###end title 73
###begin p 74
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 46 55 46 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">Fig 3 C-F</xref>
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 420 422 402 404 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 722 724 695 697 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
A. Cells were scored from assays performed in Fig 3 C-F, with results displayed as the mean percent of desmin+ myotube associated nuclei/total nuclei, +/-S.D. * p < 0.05 between young fibers + YS untreated vs + TGF-beta, + TGF-beta vs Wnt3a and + TGF-beta/Wnt3a vs Wnt3a and untreated ** p < 0.05 for young fibers + OS untreated vs anti-TGF-beta, anti-TGF-beta vs FRP3 and anti-TGF-beta/FRP3 vs FRP3 and untreated. n=3. B. Young and old satellite cells were isolated from 3 day post-injury myofiber explants and cultured overnight in Opti-MEM containing 10% isochronic sera. Cells were analyzed for levels of phospho-tyrosine GSK3beta, phosphor-serine GSK3beta and total GSK3beta levels. Actin was used a loading control. C. Quantification of B, n=5. P values indicated.
###end p 74
###begin title 75
Figure S5: Wnt does not reduce myogenic responses in young sera and FRP does not rescue myogenic responses in old sera in single myofiber systems
###end title 75
###begin p 76
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 2 26 2 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Single myofiber system 1</italic>
###xml 683 684 671 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 692 693 680 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 940 942 910 912 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 942 966 912 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Single myofiber system 2</italic>
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
###xml 212 217 <span type="species:ncbi:10090">mouse</span>
###xml 1064 1069 <span type="species:ncbi:10090">mouse</span>
###xml 1141 1146 <span type="species:ncbi:10090">mouse</span>
A.Single myofiber system 1: Single myofibers were prepared as published (14) and cultured for 24 hours in OPTI-MEM with 5% of young mouse serum (YS), YS+ TGF-beta, YS+Wnt3A, YS+TGF-beta+ Wnt3A; or with 5% of old mouse serum (OS), OS+ anti-TGF-beta, OS+FRP3, OS+anti-TGF-beta+FRP3. BrdU was added for the last 2 hours to measure proliferation. Cells were then fixed and immunostained for desmin (green) and BrdU (red), with Hoechst (blue) marking all nuclei. Percent proliferating myoblasts was quantified based on random fields of 8-10 replicates. Total migrating cells were scored in multiple random fields from the above assays and the results displayed as the mean percent of BrdU+, desmin+/total cells, +/-S.D. * p < 0.05 between young untreated vs + TGF-beta (or anti-TGF-beta), + TGF-beta vs + Wnt3a (or anti-TGF-beta vs + FRP3) and ** p < 0.05 for + TGF-beta/Wnt3a vs young untreated (or anti-TGF-beta/FRP3 vs young untreated). n=3. B.Single myofiber system 2 (14): Single myofibers were prepared and cultured exactly as published (14). (YS - with 5% young mouse sera), YS+ TGF-beta, YS+Wnt3A, YS+TGF-beta+ Wnt3A; or (OS- with 5% old mouse sera), OS+ anti-TGF-beta, OS+FRP3, OS+anti-TGF-beta+FRP3. BrdU was added for the last 2 hours to measure proliferation. Cells were then fixed and immunostained for desmin (green) and BrdU (red), with Hoechst (blue) marking all nuclei. Percent proliferating myoblasts was quantified based on random fields of 8-10 replicates. Total migrating cells were scored in multiple random fields from the above assays and the results displayed as the mean percent of BrdU+ve, desmin+ve/total cells, +/-S.D. * p < 0.05 between young untreated vs + TGF-beta (or anti-TGF-beta), + TGF-beta vs + Wnt3a (or anti-TGF-beta vs + FRP3) and ** p < 0.05 for + TGF-beta/Wnt3a vs young untreated (or anti-TGF-beta/FRP3 vs young untreated). n=3. In both single myofiber systems, TGF-beta addition reduced myoblast production in young serum, TGF-beta neutralization resulted in a much improved myogenic potential and proliferation in old serum. In contrast, exogenous Wnt3A did not decrease myogenic responses in young serum and FRP3 did not rescue myogenic responses in old serum. No synergy in regulation of myogenesis was detected between Wnt and TGF-beta.
###end p 76
###begin title 77
Figure S6: Old animals have high levels of TGF-beta receptor expression; dominant negative TGF-beta RII is expressed by virally-infected muscle stem cells
###end title 77
###begin p 78
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 536 538 530 532 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 982 983 964 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1130 1132 1110 1112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 1319 1327 1293 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 690 695 <span type="species:ncbi:10090">mouse</span>
A. TGF-beta Receptor I levels increase with age in myogenic precursor cells. Muscle in old and young mice was injured as described, harvested 3 days later and processed for myogenic precursor cells. The top panel shows a representative western blot detecting the TGF-beta Receptor I protein in young versus old myogenic precursor cells, with total actin as a loading control. Histogram of the quantified receptor immuno-signal, normalized to actin for each sample, and normalized to young for each experiment (n=2 experiments, p=0.16). B. The age of sera determines the regenerative potential of satellite cells. Young and old satellite cells were cultured either in young (Ys) or old (Os) mouse serum. Cells were analyzed by immuno-fluorescence microscopy, using anti-desmin (green) and anti-BrdU (red) antibodies. Hoechst (blue) labels all nuclei. 3 independent experiments yielded similar results and were quantified (approximately300 cells per experiment) as percent desmin/BrdU+ cells produced for each age and culture condition. *p </= 0.05 (Y cells + OS compared to Y cells + YS and O cells + OS compared to O cells + YS). C. Western blot analysis depicts detection of full length (FL) and dominant negative (DN) TGF-beta RII in isolated satellite cells, transduced with a TGF-beta RII DN-expressing lentivirus, in vitro. n=3.
###end p 78
###begin title 79
###xml 209 216 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Figure S7: Systemic pharmacological intervention does not adversely affect TGF-beta sera levels and muscle regeneration in young animals; Wnt down-regulation by FRP does not rescue regeneration of old muscle, in vivo
###end title 79
###begin p 80
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 593 595 591 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 740 742 738 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 841 843 836 838 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
###xml 899 907 894 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F4" ref-type="fig">Figure 4</xref>
###xml 1027 1029 1022 1024 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.</bold>
###xml 1727 1747 1715 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">Carlson et al., 2008</xref>
###xml 1749 1768 1737 1756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">Conboy et al., 2003</xref>
###xml 2145 2147 2126 2128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F.</bold>
###xml 1061 1065 <span type="species:ncbi:10090">mice</span>
###xml 1258 1262 <span type="species:ncbi:9925">goat</span>
A. Myofibers were isolated from young control and kinase inhibitor treated animals. Five days before the end of treatment, muscle was injured as described. BrdU was injected (intraperitoneal) at 3 days post-injury to label proliferating, fusion-competent myoblasts. Cryosections (10mum) were performed in Young and Young + Ki muscle (receiving vehicle alone), and sections were analyzed by hematoxylin/eosin (H&E) staining and immunostaining for both embryonic myosin heavy chain (eMyHC, shown in green) and BrdU incorporation (shown in red). Hoechst stains nuclei (blue). Scale bar = 100mum. B. Regeneration was quantified from muscle sections, and is presented as mean of newly-regenerated myofibers per square millimeter of injury site. C. Analysis of TGF-beta serum levels in Young + Ki animals showed no decrease, as compared to young. D. Quantified regeneration from muscle sections, shown in Figure 4, presented as mean of newly-regenerated myofibers per square millimeter of injury site. Error bars indicate S.D., n=3. E. TA and Gastroc muscle from old mice were injured by focal CTX injection (described in methods). One day after the injury, exogenous FRP3, anti-TGF-beta neutralizing antibody, FRP3+anti-TGF-beta neutralizing antibody, or control goat IgG were introduced at the injury sites. Five days after injury, muscle was cryosectioned and analyzed. Hematoxylin and eosin (H&E) staining was performed on 10mum cryosections to evaluate the efficiency of repair. As compared to non-injured tissue, newly regenerated areas have smaller myofibers with centrally located nuclei, while areas of fibrosis and inflammation are devoid of myofibers and appear white with blue nuclei. Consistently with previous reports (Carlson et al., 2008; Conboy et al., 2003) control old muscle did not regenerate well, evident by prominent scarring and inefficient formation of de-novo myofibers. FRP3 did not improve these features of regeneration. While neutralization of TGF-beta enhanced repair of old muscle, FRP3 did not synergize with TGF-beta in the aged muscle repair. At least three experiments produced similar results. Scale bar = 50mum. F. Regeneration was quantified from muscle sections such as in E, and presented as mean +/- S.D. of newly-regenerated myofibers per square millimeter of injury site. * p < 0.05 between Old + IgG and Old + FRP3 vs Old + anti-TGF-beta. n=3 to 5.
###end p 80
###begin title 81
Figures
###end title 81
###begin title 82
Old sera inhibits satellite cell responses by TGF-beta-dependent mechanism
###end title 82
###begin p 83
###xml 7 8 7 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 19 20 19 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 421 427 415 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">Fig S2</xref>
###xml 619 620 613 614 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 734 735 728 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 740 741 734 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Young (A) and old (B) myofiber-associated myogenic progenitor cells were isolated 3 days post injury and cultured overnight in Opti-MEM containing either 10% young serum (YS), 10% old (OS), TGF-beta1 antibody depleted serum alone, or with fixed amounts of recombinant TGF-beta1 in the culture system. Cells were cultured with their specific sera for 24hrs, and transferred to differentiation medium for additional 48hrs (Fig S2). BrdU was added for the last 2 hours to measure proliferation. Cells were then fixed and immunostained for desmin (green) and BrdU (red), with Hoechst (blue) marking all nuclei (as shown in C), and scored in multiple random fields from the above assays. Results are displayed as the mean percent of Desmin+/BrdU+/total cells, +/-S.D. *p < 0.05 for isochronic Y+YS/O+OS 0ng/ml, compared to 0.5ng/ml, and 5.0ng/ml compared to 0.5ng/ml; n=3.
###end p 83
###begin title 84
TGF-beta1 levels become elevated in old sera
###end title 84
###begin p 85
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 184 186 178 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 535 544 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD3" ref-type="supplementary-material">Figure S3</xref>
###xml 636 638 621 623 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 1130 1131 1109 1110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1147 1148 1126 1127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1250 1251 1229 1230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1256 1257 1235 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3 8 <span type="species:ncbi:10090">Mouse</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 187 192 <span type="species:ncbi:9606">Human</span>
###xml 280 286 <span type="species:ncbi:9606">humans</span>
A. Mouse sera TGF-beta1 becomes elevated with age. Mean serum levels, +/- s.e.m., of TGF-beta1 in young (Ym) or old (Om, n=12 for each) mice as determined by sandwich ELISA; p<0.0001. B. Human TGF-beta1 serum levels become elevated with age. TGF-beta1 levels in the serum of aged humans (AG: 65-90 years old) vs. young (YG: 20-35 year old) were determined by ELISA. Error bars (s.e.m.) represent the mean of 53 different subjects in each group; p<0.0001. Similar age-related elevations in TGF-beta1 were detected by bioactivity assay (Figure S3). Dot plots represent separate animals (A) and separate individuals (D) of indicated ages. C. Young and old myofiber explants were isolated at 3 days post-injury, and cultured overnight in Opti-MEM containing either young or old serum alone (control), or serum that had undergone activation of total TGF-beta alone, in combination with neutralizing antibody to TGF-beta1, or mixed with control serum. BrdU was added for the last 2 hours to measure proliferation. Cells were fixed and immunostained for desmin (green) and BrdU (red), with Hoechst (blue) marking all nuclei (as shown in C, quantified in D). Cells were scored in multiple random fields and results are displayed as the mean percent of Desmin+/BrdU+ cells, +/-S.D. *p < 0.05 for activated compared to control, activated + antibody compared to activated, and control compared to activate + control. n=3.
###end p 85
###begin title 86
Old serum inhibits satellite cell responses by a Wnt-independent mechanism
###end title 86
###begin p 87
###xml 17 18 17 18 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 31 32 31 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 844 845 820 821 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 903 904 876 877 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1552 1554 1513 1515 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
###xml 1695 1696 1656 1657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1704 1705 1665 1666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1881 1883 1836 1838 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F.</bold>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 108 113 <span type="species:ncbi:9606">Human</span>
###xml 218 223 <span type="species:ncbi:10090">Mouse</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
Bioactive human (A) and mouse (B) Wnt is undetectable in human or mouse sera, and is not elevated with age. Human serum was collected from 3 young (approximately20-25yrs) and 3 old (approximately65-75yrs) individuals. Mouse serum was collected from four young and four aged mice. Levels of biologically active Wnt were analyzed, using a Wnt-reporter expressing cell line. As compared to recombinant Wnt3A, no detectable Wnt activity was found in either young or old serum. Raw fluorescence values for young sera were marginally higher as compared to old sera, but both were not significantly different from the negative control (no Wnt3a samples). Inset panel shows 0.1 - 10ng/ml Wnt3a range in greater detail. Myofiber-associated myogenic progenitor cells were isolated 3 days post injury and cultured overnight in Opti-MEM containing either (C) 10% young serum (YS); YS+Wnt3A; YS+Wnt3A+ TGF-beta; or (E) 10% old (OS), OS+FRP3, OS+FRP3+anti-TGF-beta. BrdU was added for the last 2 hours to measure proliferation. Cells were then fixed and immunostained for desmin (green) and BrdU (red), with Hoechst (blue) marking all nuclei. TGF-beta addition reduced myoblast and myotube production in young serum, TGF-beta neutralization resulted in a much improved myogenic proliferation in old serum, and some cells even formed de novo myotubes. In contrast, exogenous Wnt3A did not decrease myogenic responses in young serum and FRP3 did not rescue myogenic responses in old serum. No synergy in regulation of myogenesis was detected between Wnt and TGF-beta. D. Quantification of C. Cells were scored in multiple random fields from the above assays and the results displayed as the mean percent of BrdU+, desmin+/total cells, +/-S.D. * p < 0.05 between young untreated or +Wnt3a vs +TGF-beta or +TGF-beta/Wnt3a; ** p < 0.05 for old fibers, as described above for young. n=3 for each set. F. Quantification of E. Cells were scored and displayed as in E. * p < 0.05 between young fibers + OS untreated or +FRP3 vs. +anti-TGF-beta or +anti-TGF-beta/FRP3; ** p < 0.05 for old fibers as described for young fibers; n=3 for each set.
###end p 87
###begin title 88
Down-modulation of TGF-beta signaling intensity by dominant negative TGF-beta RII attenuates old sera-imposed satellite cell regenerative potential inhibition
###end title 88
###begin p 89
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 224 232 221 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 745 746 739 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 804 806 798 800 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 857 858 851 852 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1143 1145 1137 1139 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 1257 1265 1251 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 346 351 <span type="species:ncbi:10090">mouse</span>
A. Young and old mice were injured with cardiotoxin, as described; bulk myofibers with activated satellite cells were then explanted and transiently transduced with a TGF-beta RII DN-expressing lentivirus, or control virus, in vitro. Following transduction, myofiber-derived cells were cultured for 48 hrs in OPTI-MEM + 5% young (YS) or old (OS) mouse serum. Cells were fixed and analyzed by immunofluorescence for the expression of desmin (green), and levels of BrdU incorporation (red). Hoechst (blue) labels all nuclei. The successful down-modulation of TGF-beta signaling by DN RII virus provided restoration of satellite cell regenerative potential in cells exposed to old serum, as evidenced by large number of de-novo proliferating desmin+ myoblasts that form multinucleated myotubes. Bar = 50um. B. Quantification of regenerative potential shown in A, The percent of desmin+/BrdU+ cells is shown as means with standard deviations. (*) indicates p < 0.05, as compared to treatment with young serum and control virus (Y serum + cntl.) (**) indicates p < 0.05, as compared to treatment with old serum and control virus (O serum + cntl.). C. Levels of nuclear P-Smad3 were diminished in old satellite cells transduced with DN RII-expressing lentivirus, in vitro. Old satellite cells, exposed to old serum (OS) plus control virus, or old serum plus DN RII-expressing virus (as indicated), were immunostained for P-Smad3 (green). Hoechst (blue) labels nuclei. As expected, levels of satellite cell nuclear P-Smad3 were diminished in cells transduced with DN RII-expressing virus, as compared to control (white arrow). Bar = 25um.
###end p 89
###begin title 90
Systemic pharmacological intervention lowers sera TGF-beta levels and improves regeneration in old animals
###end title 90
###begin p 91
###xml 381 383 378 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 915 916 908 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1123 1124 1112 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1162 1163 1151 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1172 1174 1161 1163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
Old or young mice were injected (subcutaneous) with a small molecule inhibitor of the TGF-beta RI Kinase (Ki), for 2 weeks. Five days before the end of treatment, muscle was injured as described. At the end of treatment, animals were sacrificed and muscle was collected. BrdU was injected (intraperitoneal) at 3 days post-injury to label proliferating, fusion-competent myoblasts. A. Cryosections (10mum) were performed in Young and Old muscle (receiving vehicle alone), Old + Ki and Old + RII (extracellular portion of TGF-beta receptor II). Sections were analyzed by hematoxylin/eosin (H&E) staining and immunostaining for both embryonic myosin heavy chain (eMyHC, shown in green) and BrdU incorporation (shown in red). Hoechst stains nuclei (blue). As shown, the regenerative outcome of old and Old + RII was worse than young (judged by scar tissue formation, de novo myofiber size/scarcity and reduction of BrdU+ nuclei within eMyHC fibers. Scale bar = 100mum. In contrast, muscle repair was improved by treatment with TGF-beta RI Kinase (Ki) small molecule inhibitor (similar to young with respect to large/dense eMyHC+ myofibers with centrally-located BrdU+ nuclei. B. Regeneration was quantified from muscle sections, and is presented as mean percent of newly-regenerated myofibers per square millimeter of injury site. Error bars indicate S.D., n=3, *p = 0.01 between Young or Old +Ki, and Old.
###end p 91
###begin title 92
Systemic pharmacological intervention lowers sera TGF-beta levels and improves regeneration in old animals
###end title 92
###begin p 93
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 515 517 503 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 806 808 791 793 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
A. Myofibers were isolated from young, old and old mice with indicated treatments for TGF-beta systemic down-modulation. Cell lysates were then analyzed by Western blot for levels of secretory TGF-beta and P-Smad3 signaling strength. Actin immunodetection was used as a loading control. As expected, higher levels of TGF-beta and P-Smad3 were detected in Old samples, as compared to Young. O + Ki pump showed reduction in both TGF-beta and P-Smad3, whereas O + Ki injection only reduced P-Smad3 signaling strength. B. Results of multiple Western blot assays were quantified (normalization of TGF-beta and P-Smad3 pixel density by actin-specific pixel density) and are depicted by relative pixel intensity, as shown; (*) indicates p <0.01, O Ki compared to Old and Young. Error bars indicate S.D. n=3 to 4. C. TGF-beta levels in serum for each animal in young, old or old + experimental treatments were determined by ELISA. Shown are mean values with standard deviations (n=3 to 12, p</=0.05 between O + Ki pump and O + anti-TGFbeta pump, and O + Ki/O + RII injection.
###end p 93
###begin p 94
We would like to thank Rik Derynck for very helpful discussions and Mary-Helen Barcellos-Hoff for advice and help with bioactive TGF-beta assays, and we also thank Roel Nusse for his expert advice on the Wnt assays. We thank Margaret A. Weitzman and Rajiv Desai for technical assistance.
###end p 94
###begin p 95
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: This work was supported by an NIH RO1 AG027252, a CIRM New Faculty Award and an Ellison's Medical Foundation grants to IMC, and a CIRM training grant to MEC.
###end p 95
###begin article-title 96
An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct
###end article-title 96
###begin article-title 97
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits
###end article-title 97
###begin article-title 98
Making sense of latent TGFbeta activation
###end article-title 98
###begin article-title 99
###xml 35 40 <span type="species:ncbi:9606">human</span>
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization
###end article-title 99
###begin article-title 100
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice
###end article-title 100
###begin article-title 101
A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis
###end article-title 101
###begin article-title 102
Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis
###end article-title 102
###begin article-title 103
Intrinsic changes and extrinsic influences of myogenic stem cell function during aging
###end article-title 103
###begin article-title 104
A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain
###end article-title 104
###begin article-title 105
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain
###end article-title 105
###begin article-title 106
###xml 45 49 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Muscle transplantation between young and old rats: age of host determines recovery
###end article-title 106
###begin article-title 107
Loss of stem cell regenerative capacity within aged niches
###end article-title 107
###begin article-title 108
Regulating the Notch pathway in embryonic, adult and old stem cells
###end article-title 108
###begin article-title 109
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells
###end article-title 109
###begin article-title 110
Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche
###end article-title 110
###begin article-title 111
Notch-mediated restoration of regenerative potential to aged muscle
###end article-title 111
###begin article-title 112
Rejuvenation of aged progenitor cells by exposure to a young systemic environment
###end article-title 112
###begin article-title 113
The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis
###end article-title 113
###begin article-title 114
Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids
###end article-title 114
###begin article-title 115
Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction
###end article-title 115
###begin article-title 116
Smad-dependent and Smad-independent pathways in TGF-beta family signalling
###end article-title 116
###begin article-title 117
The ageing immune system: is it ever too old to become young again?
###end article-title 117
###begin article-title 118
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis
###end article-title 118
###begin article-title 119
Specificity and versatility in tgf-beta signaling through Smads
###end article-title 119
###begin article-title 120
Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors
###end article-title 120
###begin article-title 121
Age-associated changes in the response of skeletal muscle cells to exercise and regeneration
###end article-title 121
###begin article-title 122
Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling
###end article-title 122
###begin article-title 123
Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation
###end article-title 123
###begin article-title 124
Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells
###end article-title 124
###begin article-title 125
Wnt signaling from the dorsal neural tube is required for the formation of the medial dermomyotome
###end article-title 125
###begin article-title 126
Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses
###end article-title 126
###begin article-title 127
Role of insulin-like growth factor binding protein (IGFBP)-3 in TGF-beta- and GDF-8 (myostatin)-induced suppression of proliferation in porcine embryonic myogenic cell cultures
###end article-title 127
###begin article-title 128
Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization
###end article-title 128
###begin article-title 129
###xml 62 77 <span type="species:ncbi:10090">transgenic mice</span>
Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor
###end article-title 129
###begin article-title 130
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice
###end article-title 130
###begin article-title 131
Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells
###end article-title 131
###begin article-title 132
Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis
###end article-title 132
###begin article-title 133
Patterning of the mesoderm involves several threshold responses to BMP-4 and Xwnt-8
###end article-title 133
###begin article-title 134
The TGF-beta family of growth and differentiation factors
###end article-title 134
###begin article-title 135
TGF-beta signal transduction
###end article-title 135
###begin article-title 136
Controlling TGF-beta signaling
###end article-title 136
###begin article-title 137
Satellite cell of skeletal muscle fibers
###end article-title 137
###begin article-title 138
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member
###end article-title 138
###begin article-title 139
Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response
###end article-title 139
###begin article-title 140
Conversion of an extracellular Dpp/BMP morphogen gradient into an inverse transcriptional gradient
###end article-title 140
###begin article-title 141
TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis
###end article-title 141
###begin article-title 142
###xml 26 31 <span type="species:ncbi:9606">human</span>
Regenerative potential of human skeletal muscle during aging
###end article-title 142
###begin article-title 143
Skeletal muscle satellite cells: changes in proliferation potential as a function of age
###end article-title 143
###begin article-title 144
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease
###end article-title 144
###begin article-title 145
Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury
###end article-title 145
###begin article-title 146
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle
###end article-title 146
###begin article-title 147
###xml 107 114 <span type="species:ncbi:8355">Xenopus</span>
Zygotic Wnt/beta-catenin signaling preferentially regulates the expression of Myf5 gene in the mesoderm of Xenopus
###end article-title 147
###begin article-title 148
Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI)
###end article-title 148
###begin article-title 149
Transforming growth factor-alpha antisense vectors can inhibit glioma cell growth
###end article-title 149
###begin article-title 150
Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis
###end article-title 150
###begin article-title 151
###xml 53 58 <span type="species:ncbi:9031">chick</span>
Compartmentalization of the somite and myogenesis in chick embryos are influenced by wnt expression
###end article-title 151
###begin article-title 152
###xml 90 100 <span type="species:ncbi:7227">Drosophila</span>
Smad affinity can direct distinct readouts of the embryonic extracellular Dpp gradient in Drosophila
###end article-title 152
###begin article-title 153
###xml 96 111 <span type="species:ncbi:10090">transgenic mice</span>
Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice
###end article-title 153
###begin article-title 154
###xml 82 97 <span type="species:ncbi:10090">transgenic mice</span>
TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice
###end article-title 154
###begin article-title 155
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta
###end article-title 155
###begin article-title 156
###xml 46 67 <span type="species:ncbi:11786">murine leukemia virus</span>
High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells
###end article-title 156
###begin p 157
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions:</bold>
###xml 35 44 35 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figures 1</xref>
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">2C,D</xref>
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">3C-F</xref>
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F4" ref-type="fig">4</xref>
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">5</xref>
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">6</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD1" ref-type="supplementary-material">S1</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD2" ref-type="supplementary-material">S2</xref>
###xml 75 80 75 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD3" ref-type="supplementary-material">S3E,F</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD4" ref-type="supplementary-material">S4</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD5" ref-type="supplementary-material">S5</xref>
###xml 90 93 90 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD6" ref-type="supplementary-material">S6B</xref>
###xml 94 104 94 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD7" ref-type="supplementary-material">S7A,B, D-F</xref>
###xml 144 154 144 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">Figures 2A</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">3B</xref>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">5</xref>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F6" ref-type="fig">6</xref>
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD3" ref-type="supplementary-material">S3D</xref>
###xml 169 174 169 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD7" ref-type="supplementary-material">S7C,D</xref>
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figure 1</xref>
###xml 257 267 257 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD6" ref-type="supplementary-material">Figure S6A</xref>
###xml 281 291 281 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD3" ref-type="supplementary-material">Figure S3C</xref>
###xml 305 314 305 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">Figure 2B</xref>
###xml 316 319 316 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="SD3" ref-type="supplementary-material">S3B</xref>
###xml 405 413 402 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F4" ref-type="fig">Figure 4</xref>
###xml 437 448 434 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F3" ref-type="fig">Figure 3A,B</xref>
###xml 542 551 539 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F1" ref-type="fig">Figures 1</xref>
###xml 553 554 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F2" ref-type="fig">2</xref>
###xml 556 557 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F4" ref-type="fig">4</xref>
###xml 559 560 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="F5" ref-type="fig">5</xref>
Author contributions: MEC provided Figures 1, 2C,D, 3C-F, 4, 5, 6, S1, S2, S3E,F, S4, S5, S6B,S7A,B, D-F and wrote the manuscript; MJC provided Figures 2A, 3B, 5, 6S3D, S7C,D, and wrote the manuscript; MH provided preliminary data for Figure 1; JJ provided Figure S6A; LB provided Figure S3C; AA provided Figure 2B, S3B and DVF provided the TGFbeta DN RII expressing retrovirus and experimental design in Figure 4; AJM provided data for Figure 3A,B; IMC designed and coordinated the study, interpreted the data, contributed to experiments in Figures 1, 2, 4, 5 and wrote the manuscript.
###end p 157

